|
SLC25A24 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.120300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.527500E-02 |
| Normal-vs-Stage2 |
5.447800E-01 |
| Normal-vs-Stage3 |
5.716600E-03 |
| Normal-vs-Stage4 |
2.815000E-04 |
| Stage1-vs-Stage2 |
7.115800E-01 |
| Stage1-vs-Stage3 |
7.868000E-02 |
| Stage1-vs-Stage4 |
5.402100E-03 |
| Stage2-vs-Stage3 |
1.955650E-01 |
| Stage2-vs-Stage4 |
6.694300E-02 |
| Stage3-vs-Stage4 |
4.248400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.993800E-02 |
| Normal-vs-AfricanAmerican |
2.87639999996259E-06 |
| Normal-vs-Asian |
7.455600E-01 |
| Caucasian-vs-AfricanAmerican |
1.187840E-04 |
| Caucasian-vs-Asian |
3.301000E-01 |
| AfricanAmerican-vs-Asian |
5.179400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.184500E-02 |
| Normal-vs-Female |
2.114400E-02 |
| Male-vs-Female |
8.263200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.906000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.613600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.741780E-02 |
| Normal-vs-Age(81-100Yrs) |
5.504700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.724000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.311800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.143400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.396000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.041600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.678190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.192400E-01 |
| Normal-vs-Grade 2 |
4.917400E-01 |
| Normal-vs-Grade 3 |
1.170870E-04 |
| Normal-vs-Grade 4 |
3.039900E-04 |
| Grade 1-vs-Grade 2 |
8.712400E-01 |
| Grade 1-vs-Grade 3 |
1.509020E-01 |
| Grade 1-vs-Grade 4 |
1.091600E-01 |
| Grade 2-vs-Grade 3 |
4.192500E-04 |
| Grade 2-vs-Grade 4 |
6.590700E-04 |
| Grade 3-vs-Grade 4 |
2.914000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.132200E-01 |
| Normal-vs-ccB subtype |
8.776500E-03 |
| ccA subtype-vs-ccB subtype |
1.036760E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.699700E-02 |
| Normal-vs-N1 |
1.290440E-01 |
| N0-vs-N1 |
6.065400E-01 |
|
|
